Publication | Closed Access
373MO Delivery and activity of SN-38 by sacituzumab govitecan in CNS tumours
15
Citations
0
References
2020
Year
Neuro-oncologyDrug TargetingMedicinePharmacologyPathologyRadiopharmaceutical TherapyTumor TargetingOncologyTumor BiologyCns Tumours
No additional data available for this publication yet. Check back later!